Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 12/2009

01-12-2009 | Research Letter

Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007

Authors: I. Guilhem, B. Balkau, F. Lecordier, J.-M. Malécot, S. Elbadii, A.-M. Leguerrier, J.-Y. Poirier, C. Derrien, F. Bonnet

Published in: Diabetologia | Issue 12/2009

Login to get access

Excerpt

To the Editor: In early studies, the use of continuous subcutaneous insulin infusion (CSII) was associated with an increased rate of diabetic ketoacidosis, caused mainly by infusion system malfunction [1‐3]. However, these findings were not confirmed in most subsequent studies [4, 5]. It has been suggested that technological improvements and/or patient and physician vigilance has lowered this risk. Nevertheless, the reliability of pumps has not been re-evaluated during the last two decades. …
Appendix
Available only for authorised users
Literature
1.
Peden NR, Braaten JT, McKendry JB (1984) Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion. Diabetes Care 7:1–5CrossRefPubMed
2.
Mecklenburg RS, Guinn TS, Sannar CA, Blumenstein BA (1986) Malfunction of continuous subcutaneous insulin infusion systems: a one-year prospective study of 127 patients. Diabetes Care 9:351–355CrossRefPubMed
3.
Chantelau E, Spraul M, Muhlhauser I, Gause R, Berger M (1989) Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience. Diabetologia 32:421–426CrossRefPubMed
4.
Lenhard MJ, Reeves GD (2001) Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med 161:2293–2300CrossRefPubMed
5.
Pickup J, Keen H (2002) Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 25:593–598CrossRefPubMed
6.
Hanaire H, Lassmann-Vague V, Jeandidier N et al (2008) Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab 34:401–423CrossRefPubMed
7.
Tschope D, Schumacher M, Gries A (1987) Technical monitoring of miniaturized insulin infusion pumps for increased therapeutical security in the treatment of type-I diabetics. Med Prog Technol 13:47–52PubMed
Metadata
Title
Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007
Authors
I. Guilhem
B. Balkau
F. Lecordier
J.-M. Malécot
S. Elbadii
A.-M. Leguerrier
J.-Y. Poirier
C. Derrien
F. Bonnet
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1549-7

Other articles of this Issue 12/2009

Diabetologia 12/2009 Go to the issue

Letter

Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes

Short Communication

Heritability and genetic correlations of insulin resistance and component phenotypes in Asian Indian families using a multivariate analysis

Review

Medial arterial calcification in diabetes and its relationship to neuropathy

Article

Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset

Article

Regression of diabetic complications by islet transplantation in the rat

Short Communication

Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits